BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32736011)

  • 1. Guidelines for Cord Blood Unit Selection.
    Politikos I; Davis E; Nhaissi M; Wagner JE; Brunstein CG; Cohen S; Shpall EJ; Milano F; Scaradavou A; Barker JN;
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2190-2196. PubMed ID: 32736011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of Cord Blood Unit by CD34
    Morishima Y; Watanabe-Okochi N; Kai S; Azuma F; Kimura T; Matsumoto K; Hatasa S; Araki N; Miyamoto A; Sekimoto T; Minemoto M; Ishii H; Uchida N; Takahashi S; Tanaka M; Shingai N; Miyakoshi S; Kozai Y; Onizuka M; Eto T; Ishimaru F; Kanda J; Ichinohe T; Atsuta Y; Takanashi M; Kato K
    Transplant Cell Ther; 2023 Oct; 29(10):622-631. PubMed ID: 37536453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Cord Blood Total Nucleated and CD34
    Barker JN; Mazis CM; Devlin SM; Davis E; Maloy MA; Naputo K; Nhaissi M; Wells D; Scaradavou A; Politikos I
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):734-744. PubMed ID: 31756534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.
    Avery S; Shi W; Lubin M; Gonzales AM; Heller G; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Barker JN
    Blood; 2011 Mar; 117(12):3277-85; quiz 3478. PubMed ID: 21149633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection.
    Dahi PB; Ponce DM; Devlin S; Evans KL; Lubin M; Gonzales AM; Byam C; Sideroff M; Wells D; Giralt S; Kernan NA; Scaradavou A; Barker JN
    Bone Marrow Transplant; 2014 Sep; 49(9):1184-6. PubMed ID: 25000459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
    Politikos I; Devlin SM; Arcila ME; Barone JC; Maloy MA; Naputo KA; Ruiz JD; Mazis CM; Scaradavou A; Avecilla ST; Dahi PB; Giralt SA; Hsu KC; Jakubowski AA; Papadopoulos EB; Perales MA; Sauter CS; Tamari R; Ponce DM; O'Reilly RJ; Barker JN
    Leukemia; 2021 Mar; 35(3):850-862. PubMed ID: 32555371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined impact of HLA-allele matching and the CD34-positive cell dose on optimal unit selection for single-unit cord blood transplantation in adults.
    Yabe T; Satake M; Odajima T; Watanabe-Okochi N; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Takanashi M; Nakajima K; Murata M; Morishima Y
    Leuk Lymphoma; 2021 Nov; 62(11):2737-2746. PubMed ID: 34128753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.
    Barker JN; Scaradavou A; Stevens CE
    Blood; 2010 Mar; 115(9):1843-9. PubMed ID: 20029048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I treat: the selection and acquisition of unrelated cord blood grafts.
    Barker JN; Byam C; Scaradavou A
    Blood; 2011 Feb; 117(8):2332-9. PubMed ID: 21149636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
    Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
    Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.
    van Rood JJ; Stevens CE; Smits J; Carrier C; Carpenter C; Scaradavou A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19952-7. PubMed ID: 19901324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved CD34
    Konuma T; Kato S; Oiwa-Monna M; Tanoue S; Ogawa M; Isobe M; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1142-1150. PubMed ID: 28390987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
    Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.
    Gragert L; Eapen M; Williams E; Freeman J; Spellman S; Baitty R; Hartzman R; Rizzo JD; Horowitz M; Confer D; Maiers M
    N Engl J Med; 2014 Jul; 371(4):339-48. PubMed ID: 25054717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.
    Dumont-Lagacé M; Feghaly A; Meunier MC; Finney M; Van't Hof W; Masson Frenet E; Sauvageau G; Cohen S
    Transplant Cell Ther; 2022 Jul; 28(7):410.e1-410.e5. PubMed ID: 35311667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.
    Yokoyama H; Morishima Y; Fuji S; Uchida N; Takahashi S; Onizuka M; Tanaka M; Yuju O; Eto T; Ozawa Y; Takada S; Takanashi M; Kato K; Kanda Y; Ichinohe T; Atsuta Y; Kanda J;
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):519-528. PubMed ID: 31715305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation.
    Jo T; Arai Y; Hatanaka K; Ishii H; Ono A; Matsuyama N; Mori J; Koh Y; Azuma F; Kimura T
    Cytotherapy; 2023 Apr; 25(4):407-414. PubMed ID: 36335019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.